Search in entities 1
Entities
Logo Name Σ Employees
BIOPHYTIS - Live Healthier Longer BIOPHYTIS - Live Healthier Longer

Une entreprise spécialisée dans le développement de thérapies transformatrices ayant un impact sur la longévité. Biophytis SA is a clinical-stage biotechnology company specialized in the development of therapeutics that are aimed at slowing the degenerative processes associated with aging. Our small molecules are aimed at stimulating biological resilience to stress during aging. Ruvembri - in regulatory and clinical phases - is our leading drug candidate is administered orally: • for the treatment of severe respiratory events related to COVID-19 following positive results in Phase 2/3 clinical study (COVA) • for the treatment of reduced mobility in elderly patients with sarcopenia, …

272 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

6 24
C.RIS Pharma C.RIS Pharma

Your partner for your preclinical development ! C.RIS Pharma is a french Contract Organization (CRO), GLP certified, specialized in in vitro and in vivo preclinical development of new active molecules against human diseases, but also in Agrofood and Cosmetic area.

53 similar entities Type: SMB Activities: deeptech biotech

0 21
4Moving Biotech 4Moving Biotech

Restoring mobility for a better quality of life 4Moving Biotech is a clinical-stage biopharmaceutical company founded in 2020. We are committed to develop first-in-class breakthrough therapies for the millions of patients suffering from osteoarthritis (OA) in the world. 4Moving Biotech is a subsidiary of 4P-Pharma, an innovation accelerator biotech company. Osteoarthritis, DMOAD, Research and Development, and Biotechnology

57 similar entities Type: Startup Activities: deeptech biotech

11 8
MedXCell SA MedXCell SA

The Cell Therapy Venture Builder MedXCell is a European cell therapy venture builder with a strong industrial mindset and a global perspective. Our focus is on technologies, techniques or novel applications in major diseases such as cancer, autoimmune, neurological and degenerative disorders. Established in 2018, we have offices in Switzerland, the EU (France) and the US (Cambridge, MA) and a multidisciplinary expert team with entrepreneurial, clinical, operational, business development and funding capabilities. Biotechnology, Cell Therapy, Immunotherapy, NK Cells, Mesenchymal Stromal Cells, Immuno-oncology, and Osteoarthritis

583 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

1 8
MaaT Pharma MaaT Pharma

Boosting Survival Through Innovative Immune Modulation MaaT Pharma is a leading, late-stage clinical company focused on developing innovative gut microbiome-driven therapies to modulate the immune system and enhance cancer patient survival. Supported by a talented team committed to making a difference for patients worldwide, the Company was founded in 2014 and is based in Lyon, France. As a pioneer, MaaT Pharma is leading the way in bringing the first microbiome-driven immunomodulator in oncology. Using its proprietary pooling and co-cultivation technologies, MaaT Pharma develops high diversity, standardized drug candidates, aiming at extending life of cancer patients. MaaT Pharma has been listed …

70 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

47 87
One2Treat One2Treat

Revolutionizing Treatment Decisions One2Treat is a fast-growing tech company incorporating the patient voice in all strategic decisions about treatment assessments in Pharma R&D. One2Treat is dedicated to transforming the way biopharmaceutical companies design and evaluate clinical trials, and how the overall medical value of a treatment may be communicated, by integrating multiple meaningful dimensions in the treatment assessment

51 similar entities Type: Startup Activities: deeptech healthtech

1 14
Access to Medicine Foundation Access to Medicine Foundation

Moving pharmaceutical companies to expand access to their products in low- & middle-income countries The Access to Medicine Foundation is an independent non-profit organisation based in the Netherlands. We seek to transform the healthcare ecosystem by motivating and mobilising companies to expand access to their essential healthcare products in low- and middle-income countries. Over the past two decades, we have demonstrated the power of data, collaboration and persuasion to trigger action by the pharmaceutical industry and scale up access to products. Our tried-and-tested approach involves defining the actions that healthcare companies should take, analysing what companies are actually doing, and …

111 similar entities Type: SMB Activities: healthtech civictech deeptech biotech Technologies: Synthetic Biology

38 62
convEyXO convEyXO

miRNA-enhanced Extracellular Vesicles Therapeutics ConvEyXO, founded in 2019 by veterans of pharma industry, builds a specialized technology platform to convey exosome-based therapeutics to the market. The company is developing is therapeutic portfolio in the field of fibrosis and chronic inflammatory disorders. The rapid development of the company is the result of collaborations with partners with a demonstrated track record in healthtech and biotech fields manufacturing, process development, upstream, downstream, extracellular vesicles, exosomes, therapeutics, cargo, Loading, 4D, and exosomes

454 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

1 17
NovaBiotics Ltd NovaBiotics Ltd

Developing first-in-class solutions for unmet health and personal care needs Results through innovation. We are an innovative biotechnology group with two divisions. Our consumer health arm has commercial products for the personal care market addressing nail, skin, scalp and hair issues. NovaBiotics pharma division has advanced clinical-stage product candidates for medically unmet, life-limiting inflammatory, infectious and respiratory disease. Our highly disruptive solutions to personal care and health needs address significant global markets. biotechnology, biologics, infectious disease, and drug discovery & development

222 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

10 15
Salvat Salvat

Driven by innovation to contribute to a healthier and happier life We share a deep commitment to service and customer service, which, combined with our professionalism, helps us achieve our primary objective: giving a longer, healthier, happier life to society by offering safe and efficacious drugs. We are able to achieve this goal through research and analysis, as well as an understanding of the needs of our patients, professionals, distributors and institutional representatives. Medicamentos de prescripción, Nutraceuticos, and Productos farmacéuticos

300 similar entities Type: SMB Activities: deeptech Technologies: Synthetic Biology

1 438
Juvisé Pharmaceuticals Juvisé Pharmaceuticals

What we provide is essential We are a pharmaceutical company dedicated to prioritizing essential medicines and aspiring to improve the health of millions of people around the world. Since our establishment in 2008, our portfolio has grown through the acquisition of 'princeps' medicines from major pharmaceutical companies. We focus on essential medicines recognized by the medical community for their therapeutic value, ensuring their production, marketing, and promotion to healthcare professionals. In doing so, we contribute each year to improving the health of over 2.5 million patients worldwide. Juvisé Pharmaceuticals is now an internationally recognized company, with medicines in neuroscience, gastroenterology, …

222 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

8 123
Valbiotis Valbiotis

Valbiotis is a commercially oriented Research & Development company committed to scientific innovation for preventing and combating metabolic and cardiovascular diseases in response to unmet medical needs. Valbiotis has adopted an innovative approach by developing a new class of health nutrition products designed to reduce the risk of major metabolic and cardiovascular diseases, relying on a multi-target strategy enabled by the use of plant-based terrestrial and marine resources. Created at the beginning of 2014 in La Rochelle, the Company has established three sites in France – Périgny, La Rochelle (17) and Riom (63) – and a subsidiary in Quebec City …

Type: NGO, Think-tanks, Ed, & Culture Startup Activities: healthtech biotech deeptech

40 62
Venn Life Sciences - part of hVIVO plc Venn Life Sciences - part of hVIVO plc

hVIVO - Making Innovation Possible Venn Life Sciences is now hVIVO. Making Innovation Possible hVIVO plc (Ticker: HVO) is a science‐led early‐phase drug development company purpose‐built to meet the growing complexity of modern clinical research. The Company operates an integrated early‐phase ecosystem that combines specialist clinical sites, advanced virology and immunology laboratories, human challenge expertise, and early drug development consulting. This unified model enables sponsors to generate rigorous, decision‐ready human data earlier in development, reducing uncertainty and accelerating progression through Phase I and II trials. With industry‐leading capabilities in respiratory and infectious disease, alongside expanding expertise in cardiometabolic and other …

123 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

7 74
MD Start MD Start

MD Start is a fund, a team of entrepreneurs and an incubator combined, aimed at transforming innovative ideas into medical realities. Our mission is to incubate medical device innovations to the point where proof-of-principle in patients is demonstrated, allowing for interest from traditional investors and our continued funding. Our team operates the projects and new companies to bridge the gap between science and clinical experience. We source innovations that are too early for large corporate or venture investors. These inventions arise from clinicians all over the world who do not wish to become entrepreneurs Our ambition is to turn these …

94 similar entities Type: Incubators & VCs SMB Activities: deeptech healthtech Technologies: Synthetic Biology

4 5
4P-Pharma 4P-Pharma

Transforming science into drug success stories Established in 2014, 4P-Pharma is a clinical-stage biotech company dedicated to addressing serious diseases with significant unmet medical needs. Our goal is to bring first-in-class therapies to patients swiftly.​ Our core is a specialized R&D engine that enhances risk management and accelerates the development process, effectively cutting down on time, costs, and uncertainty.​ We focus on developing assets combining rapid time to market and solid intellectual property. Our strategy leverages cutting-edge clinical trial designs and expedited regulatory pathways to bring our therapies to those in need as quickly as possible. Translational research, Biotechnology, Pharmaceuticals, …

228 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

35 28
MSD España MSD España

We invent for life! At MSD - known as Merck & Co., Inc. in the United States and Canada, headquartered in Rahway, New Jersey - we are united by our purpose of harnessing the potential of science to save and improve lives around the world. For more than 130 years, we have provided hope through the development of important medicines and vaccines. We aspire to be the world's leading biopharmaceutical research company and are currently at the forefront of research into innovative health solutions to advance the prevention and treatment of human and animal diseases. We foster a diverse and …

238 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

9 457
BVMed - Bundesverband Medizintechnologie BVMed - Bundesverband Medizintechnologie

BVMed is the voice of the German MedTech industry BVMed is the voice of the German MedTech industry. We represent more than 300 manufacturers, suppliers and dealers in the MedTech industry as well as medical aid service providers and homecare providers. About the industry: 212,000 employees | 93% SMEs | +€41 billion total sales | 8% investment in R&D | 68% exports Imprint: bvmed.de/imprint Medical devices, medical technology, economics, health, health policy, and economic policy

290 similar entities Type: SMB Activities: biotech deeptech healthtech Technologies: Synthetic Biology

20 46
Neocor Therapeutics Neocor Therapeutics

Neocor is dedicated to pioneering transformative therapies in cardiac care We are currently developing a novel gene therapy approach targeting ischemic and rare genetic cardiac diseases, and moving from lab preclinical trials to regulatory trials. The Company was founded in October and has received strong traction since inception. We will be looking to strengthen our human and financial ressources in the coming month in order to start the regulatory pre clinical trials. gene therapy, biotechnology, rare disease, and cardiology

343 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

6 5
Medicines for Europe Medicines for Europe

Medicines for Europe represents the generic, biosimilar and value-added medicines industries across Europe. Its vision is to provide sustainable access to high quality medicines, based on 5 important pillars: patients, quality, value, sustainability and partnership. Its members directly employ 190,000 people at over 400 manufacturing and 126 R&D sites in Europe and invest up to 17% of their turnover in R&D investment. Medicines for Europe member companies across Europe are both increasing access to medicines and driving improved health outcomes. They play a key role in creating sustainable European healthcare systems by continuing to provide high quality, effective generic medicines, …

56 similar entities Type: SMB Activities: biotech deeptech Technologies: Decarbonization

12 65
BioMelbourne Network BioMelbourne Network

Victorian industry association providing a focal point for connectivity and leadership across the Health Industry BioMelbourne Network’s mission is to foster the development of an advanced, innovation driven and sustainable health industry. As a for-purpose, industry led membership association, we encompass biotechnology, medical technology, pharmaceuticals and health innovation companies in the state of Victoria. We connect business, research, finance, health and government to support and promote the sector’s growth and facilitate the development and commercialisation of new drugs, devices, diagnostics and digital health technologies in Victoria. Since 2001, we have championed an environment that enables Victorian organisations to innovate, commercialise …

56 similar entities Type: SMB Activities: deeptech biotech healthtech Technologies: Synthetic Biology

20 15
Vivet Therapeutics Vivet Therapeutics

Vivet Therapeutics is dedicated to developing innovative gene therapy treatments for orphan diseases. Vivet Therapeutics is focused on optimizing gene therapy through collaborating with the Fundacion para la Investigacion Medica Aplicada (CIMA, Universidad de Navarra) to develop new AAV vectors specifically targeting the liver and generating new technologies to optimize gene delivery and long term expression. Gene Therapy

95 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

5 16
Samsara Therapeutics Samsara Therapeutics

Treating Neurodegenerative Disease by Restoring Autophagy At Samsara Therapeutics, we’re on a mission to unlock the full potential of autophagy activation in combating age-related neurodegenerative diseases. Our innovative approach aims to delay the progression of several debilitating conditions, offering new possibilities for patients and their families. biotechnology, biopharmaceuticals, rare disease, neurodegeneration, longevity, drug discovery, and drug development

438 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

1 12
Uncommon Uncommon

We’re using ground-breaking cell technologies to revolutionise global food production - starting with pork Uncommon Bio began with cell-based meat and pioneered RNA delivery innovations, which evolved into their most recent spin out which is focusing on changing medicine through multi-targeting. Their polysaccharide-based delivery platform enables multi-pathway cell programming, offering a safe, efficient and scalable alternative to multi-target therapies. The company is initially targeting severe lung diseases like idiopathic pulmonary fibrosis and is backed by industry leaders from BioNTech and top investors, including Sam Altman, Balderton, Lowercarbon, and Redalpine. science+art, biotech, mRNA, IPF, Pulmonary fibrosis, and delivery

579 similar entities Type: Startup Activities: biotech deeptech foodtech Technologies: Synthetic Biology

9 9
Diamante Società Benefit Srl Diamante Società Benefit Srl

Plant-based Nanotechnologies for autoimmune diseases diagnoses and therapy DIAMANTE (Nano-Technologies for Autoimmune Disease) is a biotech company focused on the use of plants for producing high value-added molecules. The company was funded in 2016 with the development of new tools in autoimmune disease diagnosis and now we are growing approaching therapeutics applications. As an innovation-oriented female company, our value proposition is the creation of novel therapeutic approach for autoimmune diseases based on the restoration of self-tolerance, using plant viruses displaying immunodominant peptides. Diamante, thanks to the Regione Veneto and particularly though the national grant POR FESR AZIONE 1.1.1 2020/2021, has …

123 similar entities Type: Startup Activities: nanotech biotech deeptech healthtech Technologies: Synthetic Biology

2 18
YSOPIA Bioscience YSOPIA Bioscience

Leading biotech in the development of innovative microbiome-based biotherapies YSOPIA Bioscience is a clinical-stage biotech company developing cutting-edge biotherapies based on the gut microbiome. Our goal is to bring safe & efficient solutions to patients with high unmet medical needs. Microbiome, Obesity, Gut modulator, Cardiometabolism, Cardiometabolic diseases, Microbiota, and Gut microbiota

297 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

4 3
VectivBio AG VectivBio AG

Life-Transforming Medicines for Patients Living with Serious Rare Diseases VectivBio AG is a clinical-stage biotechnology company focused on rare diseases with a well-defined biology that can be targeted with transformational therapeutics. VectivBio was formed in 2019 as a spinout from Therachon, a biotechnology company acquired by Pfizer, Inc., for its program in achondroplasia, with the ambition to continue to have an impact on people’s lives by bringing transformational medicines to patients with serious rare conditions. The company is led by a world-class leadership team with deep expertise in rare diseases and a track record of success in R&D, commercialization and …

147 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

2 57
MRM Health MRM Health

Redefining microbiome-based therapeutics MRM Health NV is a biopharmaceutical company focused on the discovery and development of innovative therapeutics based on the human microbiome.The company is based in a Center of Expertise for microbiome research and development in the biotech cluster in Ghent, Belgium, and has a strategic partnership with the VIB, with top research groups in both microbiome analysis and ecology and in host biology and disease research. The Company is strategically supported by strong local and international investors, including Ackermans & van Haaren, DuPont, MRM Technologies, Qbic II and VIB and has a corporate collaboration with DuPont Nutrition …

129 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

5 44
IFPMA IFPMA

We represent the innovative pharmaceutical industry globally, with a focus on innovation, equitable access, and ethics. IFPMA represents the innovative pharmaceutical industry at the international level, engaging in official relations with the United Nations and multilateral organizations. Our vision is to ensure that scientific progress translates into the next generation of medicines and vaccines that deliver a healthier future for people everywhere. To achieve this, we act as a trusted partner, bringing our members' expertise to champion pharmaceutical innovation, drive policy that supports the research, development, and delivery of health technologies, and create sustainable solutions that advance global health. Biopharmaceuticals, …

99 similar entities Type: NGO, Think-tanks, Ed, & Culture Startup Activities: biotech deeptech Technologies: Synthetic Biology

43 72
Neurentis plc Neurentis plc

NEW FRONTIERS IN NEUROSCIENCE Neurentis PLC is a late-clinical stage UK specialty pharma company, focusing on neuroscience and specialising in the development of novel treatments for mental health and other neurological and psychiatric diseases. Our product pipeline is balanced with an advanced lead drug for the treatment of Treatment-Resistant Depression (TRD) in the last stages of drug development as well as earlier stage drug candidates in collaboration with research institutions and other companies. The company is run by experienced ex-pharma industry executives, with more than 35 years’ experience in the sector each. The company’s low-risk commercial strategy is to commercialize …

392 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

1 4
Acceleron Pharma Acceleron Pharma

Accelerating drug discovery to transform patients' lives Effective 11/22/21, Acceleron Pharma Inc. is now a wholly-owned subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA (known as MSD outside the United States and Canada) http://merck.com Biopharmaceuticals, Orphan Disease Therapeutics, Rare Diseases, and Serious Diseases

520 similar entities Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology

6 67
Novartis Italia Novartis Italia

Our mission is to discover new ways to improve and extend people's lives. We rely on scientific innovation to tackle the biggest challenges in healthcare: we discover and develop innovative treatments, identifying new ways to ensure they reach as many people as possible. Novartis is headquartered in Basel, Switzerland. Our Group companies employ around 125,000 people and our products are available in 155 countries around the world. The ability to attract, nurture and retain talent is vital to continuing to develop innovative products that deliver the best patient outcomes. Read our community guidelines: https://www.novartis.com/sites/www.novartis.com/files/linkedin-community-guidelines.pdf Pharmaceuticals, Generics, Biosimilars, Cardiovascular, Metabolism, Infectious, …

197 similar entities Type: SMB Activities: biotech deeptech healthtech

3 592
REVIV Global REVIV Global

Redefining Nutritional Health. Advancing the industry through precision, data, and global innovation. REVIV has been redefining nutritional health for over 14 years, advancing the industry through precision, data, and innovation. As the global leader in IV therapy and precision nutrition, we have built the infrastructure for the future of personalized health — transforming how the world experiences precision healthcare. Backed by a dedicated Life Sciences team and clinical expertise spanning more than a decade, REVIV integrates science, technology, and clinical intelligence to pioneer a new era of intelligent health. Our multidisciplinary team of doctors, pharmacists, and scientists work across clinical …

45 similar entities Type: Startup Activities: deeptech Technologies: Synthetic Biology

0 132
Extem Extem

Extem Bioscience has been developing advanced technologies for the use of regenerative medicines and is expanding our offerings. We have identified 3 key areas that will undergo drastic shifts over the next 10 years and are in need of a multidisciplinary evidence based approach. By collaborating and co-developing with leading institutions within North America we see a brighter, healthier and trans formative future.

53 similar entities Type: Startup Activities: biotech deeptech

0 8
Synthalis Synthalis

AI-native pharmaceutical company We are an AI-native pharmaceutical company transforming scientific innovation from Africa and the UK into high-impact global health solutions. By combining cutting-edge artificial intelligence with regional biomedical expertise, we accelerate drug discovery and development—turning underutilized insights into scalable therapeutic assets. Our mission is to close the innovation gap, reduce R&D timelines, and deliver next-generation treatments to patients worldwide.

185 similar entities Type: Startup Activities: biotech healthtech Technologies: A.I.

0 1
PAVmed Inc. PAVmed Inc.

Nasdaq: PAVM PAVmed (NASDAQ: PAVM) is a highly-differentiated, multi-product medical device company employing a unique and proven business model designed to advance products from concept to commercialization much more rapidly and with significantly less capital than the typical medical device company. This model enables us to pursue an expanding pipeline strategy with a view to enhancing and accelerating value creation. cardiology, orthopedics, gastroenterology, and healthcare economics

259 similar entities Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology

2 40
Pyramid Studio Pyramid Studio

Pyramid studio embodies an unique way of leading therapeutic innovation to fuel the pipeline of pharmaceutical companies Pyramid Studio is a First-of-its-Kind venture builder dedicated to fuel the pipeline of pharmaceutical companies Pyramid Studio embodies a new way of leading therapeutic innovation through a unique build-to-buy model. Our mission is to bridge the gap for pharmaceutical companies seeking access to breakthrough innovations and delivering new therapies to patients. In practice, our team identifies and rigorously selects groundbreaking innovations from top academic teams across Europe. We collaborate closely with our Pharma partners to co-develop and co-finance these programs, ultimately delivering IND-ready …

296 similar entities Type: Incubators & VCs Startup Activities: deeptech biotech Technologies: Synthetic Biology

2 1
Landmark BioVentures AG Landmark BioVentures AG

Redefining the future of drug development with a non-conventional biopharmaceutical model Landmark BioVentures is an integrative corporate and drug development company using resources smartly to advance multiple innovative therapies. Anchored by foundational science, LBV uncovers hidden gems with unrealized therapeutic potential by connecting non-obvious dots and taking a strategically-focused active hands-on approach with each nexus company. Led by a seasoned multidisciplinary team of drug developers, entrepreneurs and deal makers, LBV harnesses its specialized and industry-relevant drug development expertise and opportunistic and creative deal-making in resource-constrained environments, to streamline drug development, focusing on holistic value creation and capture. drug development , …

90 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

14 4
LIPUM AB LIPUM AB

We have developed a biological drug SOL-116 for treatment of chronic inflammatory diseases Lipum aims for better quality of life for the millions suffering from chronic inflammatory diseases, including children. Distressed by pain, disability, and comorbidities many have to leave a normal working life in advance. We intend to increase their quality of life and decrease the considerable health care and societal costs. Inflammatory diseases, Drug development, Preclinical research, Blockbuster drugs, Chronic diseases, and Orphan drug designation

209 similar entities Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology

0 13
inven inven

Some things cannot be comprised especially quality of life saving drugs, and finding sustainable solutions to the most pressing health care challenges of our world cannot wait. That`s why, we at Inven, are committed to apply science and our resources, for providing most innovative and quality products. We strive to provide access to safe, effective and affordable medicines to the people who need them. With a strong research oriented work culture, state-of-the-art production facility and end-to-end product development capabilities - Inven is recognized as a leading, ISO 9001-2000 and WHO GMP certified, IV fluid manufacturer in the international and domestic …

137 similar entities Type: Startup Activities: biotech deeptech manufacturing Technologies: Synthetic Biology

2 38
BIO Ventures for Global Health BIO Ventures for Global Health

A results-oriented nonprofit dedicated to solving global health issues by forming partnerships with industry. BIO Ventures for Global Health (BVGH) is a Seattle-based nonprofit organization working at the crossroads of the private and public sectors to advance research and improve health. #BVGH #bvghAAI #AC3T BVGH connects people, resources, and ideas across biotechnology and pharmaceutical companies, governments, and nonprofits to solve global health issues. Programmatic activities include accelerating research and development (R&D) for diseases of poverty, expanding access to cancer medicines and technologies in Africa, and building biomedical R&D capacity in low- and middle-income countries (LMICs). global health, Africa, neglected diseases, …

57 similar entities Type: SMB Activities: healthtech biotech deeptech

14 24
IAVI IAVI

Translating science into global health impact. Translating scientific discoveries into affordable, globally accessible public health solutions. IAVI is a non-profit that develops vaccines and antibodies for HIV, tuberculosis, and emerging infectious diseases. AIDS vaccine, research and development, product development partnership, HIV/AIDS, vaccine development, global health, capacity strengthening, clinical trials, and scientific research

78 similar entities Type: SMB Activities: healthtech deeptech Technologies: Synthetic Biology

14 366
Inomed Health Inomed Health

Innovating Medical Devices Inomed Health Limited is a UK distributor of innovative medical implantable and disposable devices to the NHS and private healthcare institutions. We are a focused company supporting customers and manufacturers to constantly improve the way surgical and non-surgical treatments are performed, delivered through better medical technology to improve the lives of patients. Medical Devices, Interventional Radiology, Biopsy Devices, and Bariatric Health & General Surgery

415 similar entities Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology

1 2
Medincell Medincell

Medincell is a pharmaceutical company at commercial stage. We develop a portfolio of long-acting injectables in various therapeutic areas. Our proprietary technology BEPO® aims to ensure patient compliance, improve the effectiveness and accessibility of treatments, and reduce their environmental footprint. We collaborate with tier-one pharmaceutical companies and foundations to improve Global Health through new therapeutic options. Our mission is to contribute to the improvement and protection of the health of populations across the world. The fair sharing of the value created with all our employees is the foundation of our business model. The sustainability of MedinCell is an essential condition …

576 similar entities Type: SMB Activities: biotech deeptech healthtech Technologies: Synthetic Biology

25 176
ResoTher Pharma ResoTher Pharma

Building on innovative science to create treatments for patients in need ResoTher Pharma ApS is a biotechnology company focused on developing novel and effective peptide therapeutics for cardiovascular disease by targeting inflammation. Biotechnology, Drug Development, and Pharmaceutical Industry

541 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

0 20
LimmaTech Biologics AG LimmaTech Biologics AG

a wholly owned subsidiary of Eli Lilly and Company LimmaTech Biologics AG, a wholly owned subsidiary of Eli Lilly and Company, is a Swiss-based clinical stage biopharmaceutical company. We are advancing our proprietary vaccine pipeline to halt the increasing threat of global infections due to emerging antibiotic resistance (AMR) and sexually transmitted diseases. vaccines, research & development, biotechnology, and antimicrobial resistance

427 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

1 56
Coultreon Biopharma Coultreon Biopharma

Transforming lives with groundbreaking treatments Coultreon Biopharma's mission (formerly Onco3R Therapeutics) is to develop life-changing medicines for patients affected by chronic inflammatory diseases of high unmet medical needs. The team is leveraging their knowledge and expertise to bring transformative innovations to patients suffering from auto-immune diseases. In this field, there is an urgent need for more convenient oral drugs that can offer greater efficacy with a better safety profile. Drug Discovery, Drug Development, Immunology, Biotech, and R&D

840 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

1 34
BIOCREW Healthcare BIOCREW Healthcare

We believe in innovation, we seek value, we transform the present. Global project for health development and investment - Healthcare, Biotechnology, Digital Health, Medical Devices, MedTech, e-Health, Health Innovation, Ecosistemas de Innovación, Start Up Salud, Transferencia Tecnología, Agri-Food Tech, Spin Off, and Health Entrepreneurship

95 similar entities Type: SMB Activities: deeptech healthtech

1 1
MEDIBIOFARMA SL MEDIBIOFARMA SL

To make disease-modifying treatments available to patients with serious or life-threatening conditions Medibiofarma S.L is a clinical-stage biotechnology company founded in 2016 by a group of professionals with extensive experience in Drug Discovery in the pharmaceutical industry. We aim to generate innovative and high quality research programs based on the modulation of clinically validated therapeutic targets for the treatment of cancer and non-cancer diseases. Medicinal Chemistry, in vitro Pharmacology, Drug Discovery and Development, IP generation, IBD (Colitis, Crohn), Oncology, CNS, and Synaptopathies

637 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

1 9
Medicines for Malaria Venture Medicines for Malaria Venture

Ending malaria, rewriting the future MMV is a leading product development partnership (PDP) in the field of antimalarial drug research and development. Our vision is a world in which innovative medicines will cure and protect the vulnerable and under-served populations at risk of malaria, and ultimately help to eradicate this terrible disease. Our success in research and access & product management comes from our extensive partnership network of over 375 pharmaceutical, academic and endemic-country partners in 50 countries. www.mmv.org www.facebook.com/medicinesformalaria www.twitter.com/medsformalaria www.youtube.com/user/MMVmeds4malaria http://plus.google.com/+mmvorgmedsformalaria Research and Development, Product Development Partnership (PDP), Medicines, and Malaria

108 similar entities Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology

16 165
Radius Health, Inc. Radius Health, Inc.

We are a biopharmaceutical company dedicated to transforming the future for underserved, global patient populations in bone health and related areas. We consistently embrace opportunities to improve the lives of our patients, their caregivers, our communities, our partners, and each other.

290 similar entities Type: SMB Activities: healthtech deeptech Technologies: Synthetic Biology

3 219
Green Park Pharma Green Park Pharma

We develop, optimise and distribute innovative pharmaceutical products that offer a unique solution Who we are: Green Park Pharma UK Ltd. is a pharmaceutical company specialising in innovative drug delivery formulations. Our products address a significant market need across major global markets where the team has successfully operated. Our mission: Our mission is to develop, optimise and distribute innovative pharmaceutical products that offer a unique solution for unmet patient needs across all major global markets. Learn more about us and get in touch

278 similar entities Type: Startup Activities: healthtech deeptech biotech Technologies: Synthetic Biology

0 9
Inmedical Therapeutics Inmedical Therapeutics

Innovation in medical needs. Inmedical Therapeutics es un fabricante de productos médicos y soluciones en formato hidrogel ubicado en Vitoria. Biotecnología, Endoscopia, Farmacéutica, and Producto Médico

167 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

0 3
ten23 health ten23 health

Sterile Solutions, Built Differently. ten23 health is the human-centric and sustainable strategic partner of choice for the pharmaceutical industry and biotech start-ups for the development, manufacture, and testing of tomorrow’s medicines. Our sites in Visp and Basel 🇨🇭 support our clients in developing differentiated, stable, usable, and safe injectable treatments for patients. More about us: www.ten23.health Subscribe our newsletter: www.ten23.health/ten23-health-newsletter biopharmaceuticals, pharmaceutical industry, Contract Manufacturing, Sterile Manufacturing, Aseptic Manufacturing, Drug Device Integration, Analytical Development, Analytical Testing, Molecule Selection, Packaging , and Formulation Development

420 similar entities Type: Startup Activities: deeptech biotech healthtech Technologies: Synthetic Biology

4 231
Kezar Life Sciences Kezar Life Sciences

Pioneering first-in-class, small-molecule therapies for immune-mediated and oncologic disorders We are a clinical-stage biotechnology company combining courage, conviction and cutting-edge science to develop breakthrough treatments for immune-mediated and oncologic disorders, with the hope of helping patients overcome their disease and live a better life. We are pioneering first-in-class, small-molecule therapies that harness master regulators of cellular function and inhibit multiple drivers of disease via a single target. In modulating the function of profound intracellular regulators, our medicines have the potential for significant clinical impact in the most difficult-to-treat diseases. We believe the wide-ranging impact of our therapeutic platforms can be …

440 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

1 21
Alvotech Alvotech

Better Access. Better Lives. Our mission is to improve patient lives and the sustainability of the global healthcare ecosystem by broadening the availability and accessibility of biosimilars. Biopharmaceuticals, Research and Development, Biosimilars, Biotechnology, Pharmaceutical, Biogenerics, Health, Cell Line Development, Business Development, and Regulatory

411 similar entities Type: Startup Activities: biotech deeptech healthtech Technologies: Synthetic Biology

1 1,181
Fitabeo Therapeutics Fitabeo Therapeutics

Innovating to Enhance Quality of Life Fitabeo Therapeutics is a clinical-stage specialty pharmaceutical company that develops and commercialises a differentiated portfolio of innovative medicines focusing on indications where existing treatments are inadequate for the target population. It deploys breakthrough technologies to develop medicines that enable patient autonomy, decentralise patient care and provide superior health outcomes. Oral Thin Films, Geriatrics, Paediatrics, Patient autonomy, Equitable Access, Innovative medicines, Medication adherence, Central Nervous System, Women's Health, and Neurology

621 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

0 3
CRB Health Tech SGEIC CRB Health Tech SGEIC

Ventures at the crossroad of Health and Technology CRB is a Private Venture Capital Management firm specialized in Health Technologies. It was founded by a senior multi-disciplinary executive team. It has incorporated three previous Funds with focus on Biotech (Fund I), Medtech (Fund II), and Digital Health (Fund Nuubo). Currently incorporating the Fund III (CRB Digital Health III), a specialized Fund on Digital Health supported by a team with a large experience in startups, scaleups, corporates, and public health institutions. Based in Madrid and Barcelona, with access to the most innovative hubs in Europe. comunicacion@crossroadbiotech.com Lactose intolerance, Alzheimer, Wearable technologies, …

141 similar entities Type: Startup Activities: biotech deeptech Technologies: A.I.

9 2
GENZ Biotechnology GENZ Biotechnology

Developing novel IVD solutions Genz is a spin-off biotech company developing novel solutions from in vitro diagnostics to therapeutics. Our mission is to deliver a consistent stream of innovative, affordable, and accessible diagnostic solutions and make a remarkable impact on people’s lives. We’re focused on sustainable growth and addressing the world’s pressing health challenges; therefore, we’re able to create value for both our patients and our shareholders. To date, Genz developed 4 IVD diagnostic tests commercially legalized, attended International joint projects, partnered with top research centers in the world and published several scientific articles in international scientific journals. Biotechnology, Genetik …

313 similar entities Type: Startup Activities: biotech deeptech healthtech Technologies: Synthetic Biology

0 2
VRG Therapeutics VRG Therapeutics

Technology-driven biotech with an AI-powered miniprotein RnD platform VRG Tx is technology-driven biotech with a drug discovery platform that integrates AI with wet lab processes to develop next-generation therapeutics. Our vision is to cure diseases through previously undruggable targets and inaccessible mechanisms of action. medicinal biotechnology, research, immunology autoimmune deases , translational health research, use of genetic engineering in medicine, anti cancer drug discovery, oncological drugs, autoimmune diseases, translational research, peptide, cellandgenetherapy, and genetherapy

596 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

2 33
IMFS IMFS

Innovative Manufacturing Services (IMFS).

172 similar entities Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology

0 265
MacroGenics, Inc. MacroGenics, Inc.

MacroGenics is a leader in the discovery and development of innovative medicines that utilize our next generation antibody-based technologies. Our team of 300+ dedicated individuals is advancing a pipeline of product candidates to treat patients with cancer. Our products and platforms have attracted multiple partnerships with leading pharmaceutical and biotechnology companies around the globe. The Company considers its employees to be its most valuable asset and we are committed to providing opportunities for individuals to learn and grow as a means to further their professional development. MacroGenics' corporate culture promotes an atmosphere of innovation, open communication and teamwork where employees …

256 similar entities Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology

1 330
ADVANZ PHARMA ADVANZ PHARMA

Partner of choice in specialty, hospital, and rare disease medicines Partner of choice in specialty, hospital, and rare disease medicines ADVANZ PHARMA is a global pharmaceutical company with the purpose to improve patients’ lives by providing the specialty, hospital, and rare disease medicines they depend on. Our ambition is to be a partner of choice for the commercialisation of specialty, hospital, and rare disease medicines in Europe, Canada, and Australia. In line with our ambition, we are partnering with innovative biopharma and pharmaceutical development companies to bring medicines to patients. Headquartered in London, UK, we have commercial sales in more …

226 similar entities Type: SMB Activities: deeptech biotech healthtech Technologies: Synthetic Biology

2 738